3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
47
Lung Neoplasms
25
Neoplasms
7
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Neoplasm Metastasis
6
Colorectal Neoplasms
5
Pancreatic Neoplasms
4
Mesothelioma, Malignant
3
Melanoma
3
Colonic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Ovarian Neoplasms
2
Non-squamous Non-small Cell Lung Cancer
2
Neoplasms by Site
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma
2
Adenocarcinoma of Lung
2
Vaccinia
1
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Salivary Gland Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Interventions
Rituximab
9
ibrutinib
6
acalabrutinib
6
Cyclophosphamide
6
zanubrutinib
4
venetoclax
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Methotrexate
3
Magnetic Resonance Spectroscopy
3
Cytarabine
3
Cyclosporine
3
CT-P10
3
Bendamustine Hydrochloride
3
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Vincristine
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Etoposide
2
Doxorubicin
2
Dexamethasone
2
Calcium Dobesilate
2
treosulfan
1
pirtobrutinib
1
palbociclib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
Pemetrexed
×
30 days
×
Clear all
No trials found.